Extracellular Vesicles–Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation
- Published: 03 Dec 2019 Journal: Cells, volume 8, page 1,560 (eissn: 2073-4409,
Copyright policy)
- Publisher: MDPI AG
Hammond, S.M.. An overview of microRNAs. Adv. Drug Deliv. Rev.. 2015; 87: 3-14 [OpenAIRE] [PubMed] [DOI]
Croce, C.M.. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet.. 2009; 10: 704-714 [OpenAIRE] [PubMed] [DOI]
Daugaard, I., Hansen, T.B.. Biogenesis and function of Ago-Associated RNAs. Trends Genet.. 2017; 33: 208-219 [OpenAIRE] [PubMed] [DOI]
Yu, X., Odenthal, M., Fries, J.W.. Exosomes as miRNA carriers: Formation-function-future. Int. J. Mol. Sci.. 2016; 17 [OpenAIRE] [DOI]
Kalra, H., Drummen, G.P., Mathivanan, S.. Focus on extracellular vesicles: Introducing the next small big thing. Int. J. Mol. Sci.. 2016; 17 [OpenAIRE] [PubMed] [DOI]
Doyle, L.M., Wang, M.Z.. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019; 8 [OpenAIRE] [DOI]
Théry, C., Witwer, K.W., Aikawa, E., Alcaraz, M.J., Anderson, J.D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin-Smith, G.K.. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles. 2018; 7: 1535750 [OpenAIRE] [PubMed] [DOI]
Villarroya-Beltri, C., Baixauli, F., Gutiérrez-Vázquez, C., Sánchez-Madrid, F., Mittelbrunn, M.. Sorting it out: Regulation of exosome loading. Semin. Cancer Biol.. 2014; 28: 3-13 [OpenAIRE] [PubMed] [DOI]
Munson, P., Shukla, A.. Exosomes: Potential in cancer diagnosis and therapy. Medicines. 2015; 2: 310-327 [OpenAIRE] [PubMed] [DOI]
Hosseinahli, N., Aghapour, M., Duijf, P.H.G., Baradaran, B.. Treating cancer with microRNA replacement therapy: A literature review. J. Cell Physiol.. 2018; 233: 5574-5588 [OpenAIRE] [PubMed] [DOI]
Di Rocco, G., Baldari, S., Toietta, G.. Exosomes and other extracellular vesicles-mediated microRNA delivery for cancer therapy. Transl. Cancer Res.. 2017; 6: S1321-S1330 [OpenAIRE] [DOI]
Rupaimoole, R., Slack, F.J.. MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases. Nat. Rev. Drug Discov.. 2017; 16: 203-222 [OpenAIRE] [PubMed] [DOI]
Moore, C., Kosgodage, U., Lange, S., Inal, J.M.. The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy. Int. J. Cancer. 2017; 141: 428-436 [OpenAIRE] [PubMed] [DOI]
Brossa, A., Fonsato, V., Bussolati, B.. Anti-tumor activity of stem cell-derived extracellular vesicles. Oncotarget. 2019; 10: 1872-1873 [OpenAIRE] [PubMed] [DOI]
Bruno, S., Collino, F., Deregibus, M.C., Grange, C., Tetta, C., Camussi, G.. Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev.. 2013; 22: 758-771 [OpenAIRE] [PubMed] [DOI]
Related research
Hammond, S.M.. An overview of microRNAs. Adv. Drug Deliv. Rev.. 2015; 87: 3-14 [OpenAIRE] [PubMed] [DOI]
Croce, C.M.. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet.. 2009; 10: 704-714 [OpenAIRE] [PubMed] [DOI]
Daugaard, I., Hansen, T.B.. Biogenesis and function of Ago-Associated RNAs. Trends Genet.. 2017; 33: 208-219 [OpenAIRE] [PubMed] [DOI]
Yu, X., Odenthal, M., Fries, J.W.. Exosomes as miRNA carriers: Formation-function-future. Int. J. Mol. Sci.. 2016; 17 [OpenAIRE] [DOI]
Kalra, H., Drummen, G.P., Mathivanan, S.. Focus on extracellular vesicles: Introducing the next small big thing. Int. J. Mol. Sci.. 2016; 17 [OpenAIRE] [PubMed] [DOI]
Doyle, L.M., Wang, M.Z.. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019; 8 [OpenAIRE] [DOI]
Théry, C., Witwer, K.W., Aikawa, E., Alcaraz, M.J., Anderson, J.D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin-Smith, G.K.. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles. 2018; 7: 1535750 [OpenAIRE] [PubMed] [DOI]
Villarroya-Beltri, C., Baixauli, F., Gutiérrez-Vázquez, C., Sánchez-Madrid, F., Mittelbrunn, M.. Sorting it out: Regulation of exosome loading. Semin. Cancer Biol.. 2014; 28: 3-13 [OpenAIRE] [PubMed] [DOI]
Munson, P., Shukla, A.. Exosomes: Potential in cancer diagnosis and therapy. Medicines. 2015; 2: 310-327 [OpenAIRE] [PubMed] [DOI]
Hosseinahli, N., Aghapour, M., Duijf, P.H.G., Baradaran, B.. Treating cancer with microRNA replacement therapy: A literature review. J. Cell Physiol.. 2018; 233: 5574-5588 [OpenAIRE] [PubMed] [DOI]
Di Rocco, G., Baldari, S., Toietta, G.. Exosomes and other extracellular vesicles-mediated microRNA delivery for cancer therapy. Transl. Cancer Res.. 2017; 6: S1321-S1330 [OpenAIRE] [DOI]
Rupaimoole, R., Slack, F.J.. MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases. Nat. Rev. Drug Discov.. 2017; 16: 203-222 [OpenAIRE] [PubMed] [DOI]
Moore, C., Kosgodage, U., Lange, S., Inal, J.M.. The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy. Int. J. Cancer. 2017; 141: 428-436 [OpenAIRE] [PubMed] [DOI]
Brossa, A., Fonsato, V., Bussolati, B.. Anti-tumor activity of stem cell-derived extracellular vesicles. Oncotarget. 2019; 10: 1872-1873 [OpenAIRE] [PubMed] [DOI]
Bruno, S., Collino, F., Deregibus, M.C., Grange, C., Tetta, C., Camussi, G.. Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev.. 2013; 22: 758-771 [OpenAIRE] [PubMed] [DOI]